In order to compare the immunogenicity of the recombinant proteins, 10 active TB patients, 17 healthy LTBIs, and 15 healthy controls were selected based on the established diagnostic standard, and WBIA technology was used to evaluate the levels of IFN-γ response to purified A1D4 polyprotein and multistage antigens. The gene discussed is IFNG; the disease is tuberculosis.